Skip to main content
Journal ArticleOPEN ACCESS

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria

  • Chamma-Siqueira N
  • Negreiros S
  • Ballard S
  • et al.
New England Journal of Medicine (2022) 386(13) 1244-1253
DOI: 10.1056/nejmoa2104226
22Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background In most of the Americas, the recommended treatment to prevent relapse of Plasmodium vivax malaria is primaquine at a total dose of 3.5 mg per kilogram of body weight, despite ev...

Cite

CITATION STYLE

APA

Chamma-Siqueira, N. N., Negreiros, S. C., Ballard, S.-B., Farias, S., Silva, S. P., Chenet, S. M., … Macedo de Oliveira, A. (2022). Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria. New England Journal of Medicine, 386(13), 1244–1253. https://doi.org/10.1056/nejmoa2104226

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free